SEC Form D filing

Jabez Biosciences, Inc., 2026-03-26

An SEC Form D private-offering notice from Cranberry Twp., PA, an undisclosed offering target in Biotech. Filed 2026-03-26. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Jabez Biosciences, Inc. site↗ Verified via SEC Form D

Clinical stage biopharmaceutical company developing oncology therapies, including a small molecule DHODH inhibitor in Phase 1 trials for solid tumors and lymphoma.

Filed 2026-03-26Filed to raise Undisclosed The filer declared an indefinite offering amount; we say so instead of inventing a number.First money in 2024-06-11Raised so far $31,200HQ (as filed) Cranberry Twp., PASector Biotech web-verified against the company’s own siteStage (inferred) Pre-seedCall status Late filing
Source linked the Form D on EDGAR↗Website verified jabezbio.com↗Named in the filing 7 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source